Nitrous Oxide Manifold and Other Reduction of Emissions (NoMoreGas): a multicentre observational study evaluating pre-utilisation loss of nitrous oxide
Megan A F Thomas,Christopher J Ward,Matthew E Sinnott,Thomas W Davies,Jan M Wong,Joanna K L Wong,Gudrun Kunst,Sibtain Anwar,Pan-London Perioperative Audit and Research Network Committee,Local investigators,Chloe Baker,Farzana Begum,Elizabeth Brown,Sarah Eshelby,Luke Flower,Aidan Fullbrook,Nicole Greenshields,Leda Lignos,Shaun May,Daveena Meeks,Benjamin Milne,Mayur Murali,Louise Nolan,Chris Oddy,Mitul Patel,Kimberley Rhodes,Abtin Sadeghi,Adam Samways,Urvi Sanganee,Shilen Shah,Sarah Tian,Arif Ahmed,Natasha Amaradasa,Hamish Baillie,Duncan Baily,Rahul Bandopadhyay,Jen Berg,Nikita Bhugra,Sophie Bloomfield,David Braude,Mickey Chong,Adrian Dabrowicz,Christopher Desouza,Mustafa Eltaher,Emma Evans,Alex Feben,Aditya Gadepalli,Felicity Gallop,Mohamed Gheith,Chris Graham,Tabea Haas-Heger,Chloe Hall,Thomas Hall,Snehal Kale,Sophia Khaleeq,Aashish Koirala,Maja Kovac,Anupama Lanka,Alison Li,Cameron Macleod,Sowmia Mammen,Vafa Mansoubi,Paul Morillon,Olivia Morley,Hannah Morrison,Tooba Nawaz,Winston Ng,Michael Olivier,Lucy Partridge,Anesh Patel,Shriyam Patel,Leon Pearcey,Ruxandra Petrescu,Emily Powell,Mohammed,Rageh,Aktar Rahman,Katie Redington,Claire Ruck,Michela Saviani,Sophie Schofield,Imran Sharieff,Natalie Shields,Ariana Singh,Suzzan Sithirangathan,Richard Stead,Andrew Tan,Oliver Thompson,Rachael Tomlin,Madhvi Vaghela,Shriram Vaidya,Bhavya Vakil,Jen Van Ross,Arun Venkitaramanan,Thilini Wickramasuriya,Georgie Wicks,Indeewarie Wijesinghe,Alice Yearwood
DOI: https://doi.org/10.1016/j.bja.2024.08.027
Abstract:Background: Nitrous oxide (N2O) is a potent greenhouse gas that contributes significantly to the healthcare sector's carbon footprint. Pre-utilisation losses of N2O are up to 95%. Decommissioning manifolds can reduce these losses. Methods: Hospitals in our Greater London research network with at least one active N2O manifold were included in the Nitrous Oxide Manifold and Other Reduction of Emissions (NoMoreGas) study. N2O utilisation data were collected continuously over 5 days and extrapolated over a year, in addition to collecting procurement records from the preceding financial year. The primary outcome was the discrepancy between clinically utilised N2O and the quantity procured by hospitals, referred to as the 'N2O gap'. Secondary outcomes included anaesthetists' self-reported utilisation of N2O and their opinions on manifold decommissioning. Results: Eighteen of 53 hospitals were included. In total, 6 487 200 L of N2O were procured with a median (IQR) of 304 200 (183 600-473 400) L per site. During the 5-day data collection period, sites utilised a median (IQR) of 501 (42-1409) L of N2O. Extrapolating over a year resulted in a median (IQR) annual utilisation of 36 573 (3066-102 857) L per site and a total of 1 175 348 L. This represented an estimated 18% of the N2O procured, suggesting pre-utilisation losses of 5 311 852 L. Among surveyed anaesthetists, 70% (n=309) reported using N2O within the previous year, with one-third (n=97) using it once a week or more. There was widespread support for decommissioning manifolds. Conclusions: Consistent with other reports, the data demonstrate a substantial discrepancy between the quantities of N2O procured and utilised clinically, indicative of significant pre-utilisation losses. Our findings support the decommissioning of N2O manifolds for environmental and economic benefits.